Skip to main content

Table 1 Characteristics of patients and laboratory findings

From: Central hepatopancreatoduodenectomy—oncological effectiveness and parenchymal sparing option for diffusely spreading bile duct cancer: report of two cases

Variables Case 1 Case 2
Age (years) 66 67
Sex female male
BMI (kg/m2) 22.0 23.8
ECOG Performance Status 0 0
Serum bilirubin level at admission (mg/dL) 6.8 14.9
AST (IU/L) 27 268
ALT (IU/L) 25 514
Biliary anatomy Right antero-ventral bile duct confluent to the right hepatic duct and the right antero-dorsal bile duct independently confluent to the right posterior bile duct Right posterior bile duct draining into the left hepatic duct
Bismuth-Corlette type IIIA IIIA
Serum bilirubin level a day prior to resection (mg/dL) 0.8 1.6
Cumulative Pringle time in operation (min) 62 75
Operative blood loss (mL) 291 890
Total operation time (min) 1158 970
Serum bilirubin (POD 5) (mg/dL) 1.8 1.1
Serum AST/ ALT (POD 5) (mg/dL) 39/137 16/66
PT-INR (POD 5) 0.94 1.0
Clavien-Dindo grading of morbidity Nil Grade II—POPF
Staging AJCC (8th edition) BpBd, flat-infiltrating type, circ, 1.2 × 1.0 × 3.5 cm, pT2, por2, ly(0), v1, ne1, pN0, pDM0, pHM0, pEM0, pPV0, pA0, R0, M0 Stage II BpBd, papillary invasive type, circ, 1.2 × 0.6 × 7.0 cm, pT1, pap, ly0, v0, ne0, pN0, pDM0, pHM0, pEM0, pPV0, pA0, R0, M0 Stage I
  1. BMI body mass index, ECOG Eastern Cooperative Oncology Group, AST asparate aminotransferase, ALT alanine aminotransferase, POD post operative day, PT-INR prothrombin time international normalized ratio, POPF post operative pancreatic fistula, AJCC American Joint Committee on Cancer